Last $14.31 USD
Change Today -0.26 / -1.78%
Volume 2.0M
CLDX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/9/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Avery W. Catlin

Chief Financial Officer, Principal Accounting Officer, Senior Vice President, Treasurer and Secretary, Celldex Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

66$1,388,592
As of Fiscal Year 2013

Background*

Mr. Avery W. Catlin has been Senior Vice President and Chief Financial Officer of Celldex Therapeutics, Inc. since March 2008 and also serves as its Principal Accounting Officer, Secretary and Treasurer. Mr. Catlin has been the Chief Financial Officer of CuraGen Corp., since October 2009. Mr. Catlin served as a Senior Vice President, Chief Financial Officer and Secretary of AVANT Immunotherapeutics, Inc. since January 2000. He served as the Principal Accounting Officer ...

Read Full Background

Corporate Headquarters*

Perryville III Building
Hampton, New Jersey 08827

United States

Phone: 908-200-7500
Fax: 908-454-1911

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
University of Virginia
MBA
Babson College

Other Affiliations*

Annual Compensation*

Salary$307,735
Bonus$130,000
Total Annual Compensation$437,735

Stock Options*

All Other Compensation$5,767
Exercised Options183,333
Exercised Options Value$2,863,661
Exercisable Options218,500
Exercisable Options Value$4,104,446
Unexercisable Options192,500
Unexercisable Options Value$2,712,644
Total Value of Options$9,680,751
Total Number of Options594,333

Total Compensation*

Total Annual Cash Compensation$443,502
Total Short Term Compensation$437,735
Other Long Term Compensation$5,767
Total Calculated Compensation$1,388,592
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLDX:US $14.31 USD -0.26

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Kevin T. Conroy Chairman of The Board, Chief Executive Officer and President
Exact Sciences Corporation
$738.5K
J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
$852.8K
Stanley C. Erck Chief Executive Officer, President, Director and Member of Finance Committee
Novavax, Inc.
$448.3K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$533.3K
M. Michelle Berrey M.D., MPH.Chief Executive Officer, President, Chief Medical Officer and Director
Chimerix, Inc.
$340.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELLDEX THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.